<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--  EDGAR Online I-Metrix Xcelerate Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!--  Version: 6.0.7 -->
<!--  Creation date: 2009-07-27T06:12Z -->
<!--  Copyright (c) 2005-2009 EDGAR Online, Inc. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:amed="http://www.amedisys.com/20090630" xmlns:dei="http://xbrl.us/dei/2008-03-31" xmlns:us-gaap="http://xbrl.us/us-gaap/2008-03-31" xmlns:us-roles="http://xbrl.us/us-roles/2008-03-31" xmlns:us-types="http://xbrl.us/us-types/2008-03-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="amed-20090630.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <dei:EntityPublicFloat contextRef="eol_PE2476----0910-Q0003_STD_Inst_20080630_0" unitRef="USD" decimals="0">1326155613</dei:EntityPublicFloat>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20080630_0" unitRef="USD" decimals="-3">1660000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed contextRef="eol_PE2476----0910-Q0003_STD_Inst_20080630_0" unitRef="USD" decimals="-3">3499000</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090723_0" unitRef="Shares" decimals="0">27780111</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:Assets contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">1083398000</us-gaap:Assets>
  <us-gaap:DeferredTaxLiabilitiesCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">6344000</us-gaap:DeferredTaxLiabilitiesCurrent>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">0</us-gaap:CommitmentsAndContingencies>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USDperShareItemType" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="Shares" decimals="0">60000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="Shares" decimals="0">27830092</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="Shares" decimals="0">27719570</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">28000</us-gaap:CommonStockValue>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">-181000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">17907000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:AccountsPayable contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">17391000</us-gaap:AccountsPayable>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">344446000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">30806000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">154279000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccruedLiabilities contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">144115000</us-gaap:AccruedLiabilities>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">48326000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AssetsCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">173196000</us-gaap:AssetsCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">898000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">9487000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:Goodwill contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">749238000</us-gaap:Goodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">57332000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:Liabilities contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">440556000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">1083398000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">217263000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">196904000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
  <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">44795000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
  <us-gaap:MinorityInterest contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">873000</us-gaap:MinorityInterest>
  <us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">3834000</us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed>
  <us-gaap:OtherAssetsCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">9154000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">20988000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">8482000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USDperShareItemType" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="Shares" decimals="0">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="Shares" decimals="0">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="Shares" decimals="0">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockValue>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">8865000</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">82644000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">298357000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">641969000</us-gaap:StockholdersEquity>
  <us-gaap:TreasuryStockShares contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="Shares" decimals="0">110522</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">681000</us-gaap:TreasuryStockValue>
  <amed:MedicareObligations contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">4618000</amed:MedicareObligations>
  <amed:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE2476----0910-Q0003_STD_Inst_20090630_0" unitRef="USD" decimals="-3">642842000</amed:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20071231_0" unitRef="USD" decimals="-3">56190000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:Assets contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">1070194000</us-gaap:Assets>
  <us-gaap:DeferredTaxLiabilitiesCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">4663000</us-gaap:DeferredTaxLiabilitiesCurrent>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">0</us-gaap:CommitmentsAndContingencies>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USDperShareItemType" decimals="3">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="Shares" decimals="0">60000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="Shares" decimals="0">27191946</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="Shares" decimals="0">27083231</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">27000</us-gaap:CommonStockValue>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">-447000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">11548000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:AccountsPayable contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">18652000</us-gaap:AccountsPayable>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">326120000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">27052000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">175698000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccruedLiabilities contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">134049000</us-gaap:AccruedLiabilities>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">39208000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AssetsCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">194350000</us-gaap:AssetsCurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">2847000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">7944000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:Goodwill contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">733881000</us-gaap:Goodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">42388000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:Liabilities contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">508076000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">1070194000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">204627000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">285942000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
  <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">42632000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
  <us-gaap:MinorityInterest contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">783000</us-gaap:MinorityInterest>
  <us-gaap:OtherAssetsCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">7719000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">20317000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">5959000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USDperShareItemType" decimals="3">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="Shares" decimals="0">5000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="Shares" decimals="0">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="Shares" decimals="0">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">0</us-gaap:PreferredStockValue>
  <us-gaap:PrepaidExpenseCurrent contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">8086000</us-gaap:PrepaidExpenseCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">79258000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">236252000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:StockholdersEquity contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">561335000</us-gaap:StockholdersEquity>
  <us-gaap:TreasuryStockShares contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="Shares" decimals="0">108715</us-gaap:TreasuryStockShares>
  <us-gaap:TreasuryStockValue contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">617000</us-gaap:TreasuryStockValue>
  <amed:MedicareObligations contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">4631000</amed:MedicareObligations>
  <amed:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE2476----0910-Q0003_STD_Inst_20081231_0" unitRef="USD" decimals="-3">562118000</amed:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USDperShareItemType" decimals="2">0.77</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USDperShareItemType" decimals="2">0.76</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CostOfServices contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">148754000</us-gaap:CostOfServices>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">5419000</us-gaap:DepreciationAndAmortization>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">33723000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">13337000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">5448000</us-gaap:InterestExpense>
  <us-gaap:InvestmentIncomeInterestAndDividend contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">270000</us-gaap:InvestmentIncomeInterestAndDividend>
  <us-gaap:LaborAndRelatedExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">72751000</us-gaap:LaborAndRelatedExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">20384000</us-gaap:NetIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">-5030000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">38753000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">40044000</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">148000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">5682000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:SalesRevenueServicesNet contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">312671000</us-gaap:SalesRevenueServicesNet>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">1268000</us-gaap:ShareBasedCompensation>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="Shares" decimals="-3">26811000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="Shares" decimals="-3">26341000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <amed:CostAndOperatingExpenses contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">273918000</amed:CostAndOperatingExpenses>
  <amed:ProfitLoss contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">20386000</amed:ProfitLoss>
  <amed:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE2476----0910-Q0003_STD_p3m_20080630_0" unitRef="USD" decimals="-3">2000</amed:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USDperShareItemType" decimals="2">1.29</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USDperShareItemType" decimals="2">1.27</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CostOfServices contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">178437000</us-gaap:CostOfServices>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">6919000</us-gaap:DepreciationAndAmortization>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">57577000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">22455000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:InterestExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">2958000</us-gaap:InterestExpense>
  <us-gaap:InvestmentIncomeInterestAndDividend contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">52000</us-gaap:InvestmentIncomeInterestAndDividend>
  <us-gaap:LaborAndRelatedExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">82055000</us-gaap:LaborAndRelatedExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">35083000</us-gaap:NetIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">-1963000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">59540000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">42425000</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">943000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">5737000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:SalesRevenueServicesNet contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">377892000</us-gaap:SalesRevenueServicesNet>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">2779000</us-gaap:ShareBasedCompensation>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="Shares" decimals="-3">27541000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="Shares" decimals="-3">27124000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <amed:CostAndOperatingExpenses contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">318352000</amed:CostAndOperatingExpenses>
  <amed:ProfitLoss contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">35122000</amed:ProfitLoss>
  <amed:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE2476----0910-Q0003_STD_p3m_20090630_0" unitRef="USD" decimals="-3">39000</amed:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">-54530000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USDperShareItemType" decimals="2">1.40</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USDperShareItemType" decimals="2">1.38</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CostOfServices contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">249522000</us-gaap:CostOfServices>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">6386000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">9843000</us-gaap:DepreciationAndAmortization>
  <us-gaap:EquityMethodInvestmentDividendsOrDistributions contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">112000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">1645000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">-483000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">60932000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">387000</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">24109000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxesPaid contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">16848000</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">-8237000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">30416000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">24633000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">219000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">1227000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:InterestExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">6574000</us-gaap:InterestExpense>
  <us-gaap:InterestPaid contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">4072000</us-gaap:InterestPaid>
  <us-gaap:InvestmentIncomeInterestAndDividend contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">738000</us-gaap:InvestmentIncomeInterestAndDividend>
  <us-gaap:LaborAndRelatedExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">118699000</us-gaap:LaborAndRelatedExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">347733000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">-459807000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">57544000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">36848000</us-gaap:NetIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">-5659000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NotesIssued contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">1946000</us-gaap:NotesIssued>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">66591000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">69505000</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">177000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:PaymentsOfFinancingCosts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">8124000</us-gaap:PaymentsOfFinancingCosts>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">447124000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">0</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">11627000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromRepaymentsOfBankOverdrafts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">1657000</us-gaap:ProceedsFromRepaymentsOfBankOverdrafts>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">250000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromLinesOfCredit contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">145000000</us-gaap:ProceedsFromLinesOfCredit>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">1155000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockPlans contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">1688000</us-gaap:ProceedsFromStockPlans>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">9277000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:RepaymentsOfLinesOfCredit contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">32500000</us-gaap:RepaymentsOfLinesOfCredit>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">12788000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:SalesRevenueServicesNet contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">525758000</us-gaap:SalesRevenueServicesNet>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">2321000</us-gaap:ShareBasedCompensation>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="Shares" decimals="-3">26741000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="Shares" decimals="-3">26267000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <amed:AmortizationOfDeferredFinancingCosts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">419000</amed:AmortizationOfDeferredFinancingCosts>
  <amed:IncreaseDecreaseOtherCurrentAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">484000</amed:IncreaseDecreaseOtherCurrentAssets>
  <amed:ProceedsFromSaleOfDeferredCompensationPlanAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">600000</amed:ProceedsFromSaleOfDeferredCompensationPlanAssets>
  <amed:CostAndOperatingExpenses contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">459167000</amed:CostAndOperatingExpenses>
  <amed:WriteOffOfDeferredFinancingCosts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">406000</amed:WriteOffOfDeferredFinancingCosts>
  <amed:EmployeeMatchExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">5357000</amed:EmployeeMatchExpense>
  <amed:PurchasesOfDeferredCompensationPlanAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">1659000</amed:PurchasesOfDeferredCompensationPlanAssets>
  <amed:ProfitLoss contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">36823000</amed:ProfitLoss>
  <amed:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE2476----0910-Q0003_STD_p6m_20080630_0" unitRef="USD" decimals="-3">-25000</amed:NetIncomeLossAttributableToNoncontrollingInterest>
  <dei:DocumentType contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">10-Q</dei:DocumentType>
  <dei:AmendmentFlag contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">false</dei:AmendmentFlag>
  <dei:AmendmentDescription contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">N.A.</dei:AmendmentDescription>
  <dei:DocumentPeriodEndDate contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">2009-06-30</dei:DocumentPeriodEndDate>
  <dei:EntityRegistrantName contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">AMEDISYS INC</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">0000896262</dei:EntityCentralIndexKey>
  <dei:TradingSymbol contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">AMED</dei:TradingSymbol>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityWellKnownSeasonedIssuer contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">Yes</dei:EntityWellKnownSeasonedIssuer>
  <dei:EntityVoluntaryFilers contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">No</dei:EntityVoluntaryFilers>
  <dei:EntityCurrentReportingStatus contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">Large Accelerated Filer</dei:EntityFilerCategory>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">-1949000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USDperShareItemType" decimals="2">2.30</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USDperShareItemType" decimals="2">2.26</us-gaap:EarningsPerShareDiluted>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">&lt;div&gt;
&lt;h5 align="left"&gt;&lt;/h5&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;6. COMMITMENTS AND
CONTINGENCIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Legal
Proceedings&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;&lt;font size="+0"&gt;We are
involved in legal actions in the normal course of business, some of
which seek monetary damages, including claims for punitive damages.
We do not believe that these actions, when finally concluded and
determined, will have a material impac&lt;/font&gt;t on our consolidated
financial condition, results of operations or cash
flows.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Insurance&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;We are obligated for certain
costs associated with our insurance programs, including employee
health, workers&amp;#8217; compensation and professional liability.
While we maintain various insurance programs to cover these risks,
we are self-insured for a substantial portion of our potential
claims. We recognize our obligations associated with these costs in
the period in which a claim is incurred, including with respect to
both reported claims and claims incurred but not reported, up to
specified deductible limits. These costs have generally been
estimated based on historical data of our claims experience. Such
estimates, and the resulting reserves, are reviewed and updated by
us on a quarterly basis.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Our health insurance has a
retention limit of $0.3 million, our workers&amp;#8217; compensation
insurance has a retention limit of $0.4 million and our
professional liability insurance has a retention limit of $0.3
million.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:DebtDisclosureTextBlock contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">&lt;div&gt;
&lt;h5 align="left"&gt;&lt;/h5&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;5. LONG-TERM
OBLIGATIONS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Long-term debt, including
capital lease obligations, consisted of the following for the
periods indicated (amounts in millions):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 12px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="78%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;June&amp;#160;30,&amp;#160;2009&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;December&amp;#160;31,&amp;#160;2008&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Senior Notes:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;$35.0 million Series A Notes;
semi-annual interest only payments; interest rate at 6.07%&amp;#160;per
annum; due March&amp;#160;25, 2013&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;$30.0 million Series B Notes;
semi-annual interest only payments; interest rate at 6.28%&amp;#160;per
annum; due March&amp;#160;25, 2014&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;30.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;30.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;$35.0 million Series C Notes;
semi-annual interest only payments; interest rate at 6.49%&amp;#160;per
annum; due March&amp;#160;25, 2015&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Term Loan; $7.5 million principal
payments plus accrued interest payable quarterly; interest rate at
ABR Rate plus applicable percentage or Eurodollar Rate plus the
applicable percentage (1.33% and 3.08% at June&amp;#160;30, 2009 and
December&amp;#160;31, 2008, respectively); due March&amp;#160;26,
2013&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;112.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;127.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;$250.0 million Revolving Credit
Facility; interest only quarterly payments; interest rate at ABR
Rate plus applicable percentage or Eurodollar Rate plus the
applicable percentage (1.34% and 1.72% at June&amp;#160;30, 2009 and
December&amp;#160;31, 2008, respectively); due March&amp;#160;26,
2013&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;11.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;80.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Promissory notes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;18.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;20.3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Capital leases&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;0.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;0.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;241.7&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;328.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Current portion of long-term
obligations&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(44.8&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(42.6&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Total&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;196.9&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;285.9&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Our weighted-average interest
rates for our five year Term Loan (the &amp;#8220;Term Loan&amp;#8221;) and
our $250.0 million, five year Revolving Credit Facility (the
&amp;#8220;Revolving Credit Facility&amp;#8221;) were as
follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 12px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="68%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"
nowrap="nowrap" align="middle" colspan="4"&gt;&lt;font face=
"Times New Roman" size=
"1"&gt;&lt;b&gt;For&amp;#160;the&amp;#160;three-month&amp;#160;periods&lt;br /&gt;
ended&amp;#160;June&amp;#160;30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"
nowrap="nowrap" align="middle" colspan="4"&gt;&lt;font face=
"Times New Roman" size=
"1"&gt;&lt;b&gt;For&amp;#160;the&amp;#160;six-month&amp;#160;periods&lt;br /&gt;
ended&amp;#160;June&amp;#160;30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;2009&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;2008&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;2009&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;2008&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Term Loan&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;%&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;4.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;%&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;2.1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;%&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;4.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;%&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Revolving Credit Facility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1.6&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;%&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;4.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;%&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1.7&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;%&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;4.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;%&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;As of June&amp;#160;30, 2009, our
total leverage ratio (used to compute the margin and commitment
fees, described in more detail in Note 5 of the financial
statements included in our Form 10-K) was 1.0, our fixed charge
coverage ratio was 2.4 and we were in compliance with the covenants
associated with our long-term obligations.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;The following table presents
our availability under our $250.0 million Revolving Credit Facility
as of June&amp;#160;30, 2009 (amounts in millions):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 12px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="94%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Total Revolving Credit
Facility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;250.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Less: outstanding revolving credit
loans&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(10.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Less: outstanding swingline
loans&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(1.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Less: outstanding letters of
credit&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(10.9&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Remaining availability under the
Revolving Credit Facility&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;228.1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;See Note 5 of the financial
statements included in our Form 10-K for additional details on our
outstanding long-term obligations.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;

</us-gaap:DebtDisclosureTextBlock>
  <us-gaap:CostOfServices contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">343477000</us-gaap:CostOfServices>
  <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">5154000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">13201000</us-gaap:DepreciationAndAmortization>
  <us-gaap:EquityMethodInvestmentDividendsOrDistributions contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">150000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">637000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">-535000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;4. GOODWILL AND OTHER INTANGIBLE
ASSETS, NET&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;The following table
summarizes the activity related to our goodwill and our other
intangible assets, net as of and for the six-month period ended
June&amp;#160;30, 2009 (amounts in millions):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 12px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="65%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="2"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="12"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Other Intangible Assets, Net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Certificates&lt;br /&gt;
of&amp;#160;Need&amp;#160;and&lt;br /&gt;
Licenses&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Acquired&lt;br /&gt;
Name of&lt;br /&gt;
Business&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Non-Compete&lt;br /&gt;
Agreements&amp;#160;&amp;amp;&lt;br /&gt;
Reacquired&lt;br /&gt;
Franchise&lt;br /&gt;
Rights (1)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Balances at December&amp;#160;31,
2008&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;733.9&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;32.7&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;3.3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;6.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;42.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Additions&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;20.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1.9&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;6.6&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;9.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Adjustments related to
acquisitions&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(5.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;7.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;7.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Amortization&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(1.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(1.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Balances at June&amp;#160;30,
2009&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;749.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;42.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;3.8&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;11.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;57.3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style=
"MARGIN-TOP: 0px; MARGIN-BOTTOM: 2px; WIDTH: 10%; LINE-HEIGHT: 8px; BORDER-BOTTOM: #000000 0.5pt solid"&gt;
&amp;#160;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0"
cellpadding="0" width="100%" border="0"&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td valign="top" align="left" width="4%"&gt;&lt;font face=
"Times New Roman" size="2"&gt;(1)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;
&lt;p align="justify"&gt;&lt;font face="Times New Roman" size="2"&gt;The
weighted-average amortization period of our non-compete agreements
and reacquired franchise rights is 3.5 years.&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;During 2009, we adjusted
goodwill by a net $5.2 million primarily in association with our
completion of purchase accounting adjustments for our 2008
acquisition of TLC, where we allocated an additional $7.5 million
to the estimated fair value of Medicare licenses acquired and
decreased the estimated fair value of the deferred tax liability
assumed by $2.9 million.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;

</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">101901000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">1066000</us-gaap:IncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">39741000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxesPaid contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">27915000</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">1754000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">-9465000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">9489000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">-1775000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">2509000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:InterestExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">6412000</us-gaap:InterestExpense>
  <us-gaap:InterestPaid contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">5920000</us-gaap:InterestPaid>
  <us-gaap:InvestmentIncomeInterestAndDividend contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">133000</us-gaap:InvestmentIncomeInterestAndDividend>
  <us-gaap:LaborAndRelatedExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">155080000</us-gaap:LaborAndRelatedExpense>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">-90762000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">-41485000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">130298000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">62105000</us-gaap:NetIncomeLoss>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">-4558000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NotesIssued contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">0</us-gaap:NotesIssued>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">106459000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;1. NATURE OF OPERATIONS,
CONSOLIDATION AND PRESENTATION OF FINANCIAL
STATMENTS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Amedisys, Inc., a Delaware
corporation, and its consolidated subsidiaries
(&amp;#8220;Amedisys,&amp;#8221; &amp;#8220;we,&amp;#8221; &amp;#8220;us,&amp;#8221; or
&amp;#8220;our&amp;#8221;) are a multi-state provider of home health and
hospice services with approximately 87% of our net service revenue
derived from Medicare for the three and six-month periods ended
June&amp;#160;30, 2009 and 2008. As of June&amp;#160;30, 2009, we had 498
Medicare-certified home health and 51 Medicare-certified hospice
agencies in 38 states within the United States, the District of
Columbia and Puerto Rico.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Basis of
Presentation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;In our opinion, the
accompanying unaudited condensed consolidated financial statements
contain all adjustments (consisting solely of normal recurring
adjustments) necessary to present fairly our financial position,
our results of operations and our cash flows in accordance with
U.S. generally accepted accounting principles (&amp;#8220;U.S.
GAAP&amp;#8221;). Our results of operations for the interim periods
presented are not necessarily indicative of results of our
operations for the entire year and have not been audited by our
independent auditors.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Certain information and
footnote disclosures normally included in financial statements
prepared in accordance with U.S. GAAP have been condensed or
omitted from the interim financial information presented. This
report should be read in conjunction with our consolidated
financial statements and related notes included in our Annual
Report on Form 10-K for the year ended December&amp;#160;31, 2008 as
filed with the Securities and Exchange Commission
(&amp;#8220;SEC&amp;#8221;) on February&amp;#160;17, 2009 (the &amp;#8220;Form
10-K&amp;#8221;), which includes information and disclosures not
included herein.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Use of
Estimates&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Our accounting and reporting
policies conform with U.S. GAAP. In preparing the unaudited
condensed consolidated financial statements, we are required to
make estimates and assumptions that impact the amounts reported in
the condensed consolidated financial statements and accompanying
notes. Actual results could materially differ from those
estimates.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Reclassifications and
Comparability&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Certain reclassifications
have been made to prior periods&amp;#8217; financial statements in
order to conform them to the current period&amp;#8217;s presentation.
Our adoption of Statement of Financial Accounting Standards
(&amp;#8220;SFAS&amp;#8221;) No.&amp;#160;160, &lt;i&gt;Noncontrolling Interests in
Consolidated Financial Statements &amp;#8212; Amendment to ARB
No.&amp;#160;51&lt;/i&gt; (&amp;#8220;SFAS 160&amp;#8221;) required that we change
the name of minority interests to noncontrolling interests for all
periods presented. Additionally, it required that noncontrolling
interests be included as part of our total reported equity in the
accompanying condensed consolidated balance sheets and reordered
the presentation of such amounts in the condensed consolidated
income statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Additionally, we adopted SFAS
No.&amp;#160;141 (Revised), &lt;i&gt;Business Combinations&lt;/i&gt; (&amp;#8220;SFAS
141R&amp;#8221;) on January&amp;#160;1, 2009.&amp;#160;SFAS 141R amended the
requirements of how to account for business combinations, by
requiring the expensing of most acquisition related costs
associated with an acquisition as opposed to including them as part
of the purchase price, as allowed under SFAS No.&amp;#160;141,
&lt;i&gt;Business Combinations&lt;/i&gt; (&amp;#8220;SFAS 141&amp;#8221;). As a result,
we expensed $0.1 million and $0.4 million in acquisition related
transaction costs during the three and six-month periods ended
June&amp;#160;30, 2009 in other general and administrative expenses in
our condensed consolidated income statement. This compares to $1.0
million and $3.3 million in such costs that were included in the
purchase price of acquisitions that occurred during the three and
six-month periods ended June&amp;#160;30, 2008.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Additionally, as a result of
our rapid growth through acquisition and start-up activities, our
operating results may not be comparable for the periods that are
presented.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Principles of
Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;These condensed consolidated
financial statements include the accounts of Amedisys, Inc. and our
wholly owned subsidiaries. All significant intercompany accounts
and transactions have been eliminated in our accompanying condensed
consolidated financial statements, and business combinations
accounted for as purchases have been included in our condensed
consolidated financial statements from their respective dates of
acquisition. In addition to our wholly owned subsidiaries, we also
have certain equity investments that are accounted for as set forth
below.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;i&gt;Equity Investments&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;We consolidate subsidiaries
and/or joint ventures when the entity is a variable interest entity
and we are the primary beneficiary, as defined in the Financial
Accounting Standards Board Interpretation No.&amp;#160;46 (Revised),
&lt;i&gt;Consolidation of Variable Interest Entities&lt;/i&gt; (&amp;#8220;FIN
46R&amp;#8221;), or if we have controlling interests in the entity,
which is generally ownership in excess of 50%. Third party equity
interests in our consolidated joint ventures are reflected as
noncontrolling interests in our condensed consolidated financial
statements.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size=
"1"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;!--##PBStart##--&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;For subsidiaries or joint
ventures in which we do not have a controlling interest or for
which we are not the primary beneficiary, as defined by FIN 46R, we
record such investments under the equity method of
accounting.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">84691000</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">1721000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:PaymentsOfFinancingCosts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">0</us-gaap:PaymentsOfFinancingCosts>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">19205000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">5214000</us-gaap:PaymentsToAcquireIntangibleAssets>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">15056000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:ProceedsFromRepaymentsOfBankOverdrafts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">-3379000</us-gaap:ProceedsFromRepaymentsOfBankOverdrafts>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromLinesOfCredit contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">50200000</us-gaap:ProceedsFromLinesOfCredit>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">454000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockPlans contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">2734000</us-gaap:ProceedsFromStockPlans>
  <us-gaap:ProvisionForDoubtfulAccounts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">11903000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:RepaymentsOfLinesOfCredit contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">119700000</us-gaap:RepaymentsOfLinesOfCredit>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">21708000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:SalesRevenueServicesNet contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">719731000</us-gaap:SalesRevenueServicesNet>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;3. ACQUISITIONS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Each of the following
acquisitions was completed in order to pursue our strategy of
increasing our market presence by expanding our service base and
enhancing our position in certain geographic areas as a leading
provider of home health and hospice services. The purchase price
paid for each acquisition was negotiated through arm&amp;#8217;s length
transactions, with consideration based on our analysis of, among
other things, comparable acquisitions and expected cash flows for
each transaction. Each of the following acquisitions was accounted
for as a purchase and is included in our condensed consolidated
financial statements from the respective acquisition date. Goodwill
generated from the acquisitions was recognized for the excess of
the purchase price over tangible and identifiable intangible assets
because of the expected contributions of each acquisition to our
overall corporate strategy.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Summary of 2009
Acquisitions&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;The following table presents
details of our acquisitions (dollars in millions):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 12px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="2%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td width="13%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td width="47%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="5"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Purchase Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="8"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Purchase Price Allocation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="3"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Number of&lt;br /&gt;
Agencies&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;
&lt;p style="WIDTH: 9pt; BORDER-BOTTOM: #000000 1px solid"&gt;&lt;font face=
"Times New Roman" size="1"&gt;&lt;b&gt;(1)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"&gt;
&lt;font face="Times New Roman" size="1"&gt;&lt;b&gt;Date&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="center"&gt;
&lt;font face="Times New Roman" size="1"&gt;&lt;b&gt;Acquired
Entity&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px" align="center"&gt;
&lt;font face="Times New Roman" size="1"&gt;&lt;b&gt;(location of
assets)&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Cash&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Promissory&lt;br /&gt;
Note&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Other&lt;br /&gt;
Intangible&lt;br /&gt;
Assets&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Other&amp;#160;Assets&lt;br /&gt;
(Liabilities),&lt;br /&gt;
Net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size="1"&gt;&lt;b&gt;Home&lt;br /&gt;
Health&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Hospice&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size="1"&gt;&lt;b&gt;Number&lt;br /&gt;
of&lt;br /&gt;
States&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&amp;#8224;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;June&amp;#160;15,&amp;#160;2009&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size="2"&gt;Jackson,
Mississippi agency&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;2.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;2.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;0.3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" nowrap="nowrap"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&amp;#8224;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;April&amp;#160;1,&amp;#160;2009&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size="2"&gt;Upper
Chesapeake Health System and St. Joseph Medical Center&lt;br /&gt;
(Baltimore, Maryland)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;9.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;2.3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;10.7&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(0.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&amp;#8224;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;March&amp;#160;12,&amp;#160;2009&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size="2"&gt;White
River Health System&lt;br /&gt;
(Batesville, Arkansas)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;3.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;2.6&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;0.7&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(0.1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&amp;#8224;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;February&amp;#160;3,&amp;#160;2009&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size="2"&gt;Arizona
Home Rehabilitation and Health Care and Yuma Home Care&lt;br /&gt;
(Yuma, Arizona)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;4.3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;5.0&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;0.8&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;19.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;3.8&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;20.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;2.8&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;(0.3&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" nowrap="nowrap"&gt;&lt;font face="Times New Roman" size=
"2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;7&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;font face="Times New Roman" size=
"2"&gt;4&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style=
"MARGIN-TOP: 0px; MARGIN-BOTTOM: 2px; WIDTH: 10%; LINE-HEIGHT: 8px; BORDER-BOTTOM: #000000 0.5pt solid"&gt;
&amp;#160;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0"
cellpadding="0" width="100%" border="0"&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td valign="top" align="left" width="4%"&gt;&lt;font face=
"Times New Roman" size="2"&gt;(1)&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;
&lt;p align="justify"&gt;&lt;font face="Times New Roman" size="2"&gt;The
acquisitions marked with the cross symbol (&amp;#8224;) were asset
purchases.&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size=
"1"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;2008 TLC Health Care Services,
Inc. (&amp;#8220;TLC&amp;#8221;) Acquisition&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;During the three-month period
ended March&amp;#160;31, 2009, the remaining $12.8 million of the
purchase price that was in escrow in connection with the TLC
acquisition for indemnification and working capital price
adjustments was released and paid to the selling stockholders under
the indemnification provisions of the TLC acquisition agreement.
Additionally, we finalized our purchase accounting for the TLC
acquisition during the three-month period ended March&amp;#160;31,
2009.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size=
"1"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;The following table
summarizes, as of March&amp;#160;31, 2009, the estimated fair values of
the TLC assets acquired and liabilities assumed on March&amp;#160;26,
2008 (amounts in millions):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 12px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="94%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Patient accounts receivable,
net&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;37.8&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Property and equipment&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;330.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Intangible assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;19.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Deferred taxes&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;38.2&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Other current assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Other assets&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;1.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Current liabilities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;(32.1&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;)&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;396.4&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" nowrap="nowrap"&gt;&lt;font face="Times New Roman"
size="2"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Our purchase price
finalization included decreasing goodwill by $5.5 million primarily
as the net result of allocating an additional $7.5 million to the
estimated fair value assigned to Medicare licenses acquired and a
$2.9 million reduction in the estimated fair value of the deferred
tax liability assumed.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;See Note 2 of the financial
statements included in our Form 10-K for additional details on our
2008 acquisitions.&lt;/font&gt;&lt;/p&gt;


&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">4920000</us-gaap:ShareBasedCompensation>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">&lt;div&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;2. SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Revenue
Recognition&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;We earn net service revenue
through our home health and hospice agencies by providing a variety
of services almost exclusively in the homes of our patients. This
net service revenue is earned and billed either on an episode of
care basis (on a 60-day episode of care basis for home health
services and on a 90-day episode of care basis for the first two
hospice episodes of care and on a 60-day episode of care basis for
any subsequent hospice episodes), on a per visit basis or on a
daily basis depending upon the payment terms and conditions
established with each payor for services provided. We refer to home
health revenue earned and billed on a 60-day episode of care as
episodic-based revenue. For the services we provide, Medicare is
our largest payor.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;When we record our service
revenue, we record it net of estimated revenue adjustments and
contractual adjustments to reflect amounts we estimate to be
realizable for services provided, as discussed below. We believe,
based on information currently available to us and based on our
judgment, that changes to one or more factors that impact the
accounting estimates (such as our estimates related to revenue
adjustments, contractual adjustments and episodes in progress) we
make in determining net service revenue, which changes are likely
to occur from period to period, will not materially impact our
reported consolidated financial condition, results of operations,
cash flows or our future financial results.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;i&gt;Home Health Revenue
Recognition&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;u&gt;Medicare Revenue&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Net service revenue is
recorded under the Medicare payment program (&amp;#8220;PPS&amp;#8221;)
based on a 60-day episode payment rate that is subject to
adjustment based on certain variables including, but not limited
to: (a)&amp;#160;an outlier payment if our patient&amp;#8217;s care was
unusually costly; (b)&amp;#160;a low utilization adjustment
(&amp;#8220;LUPA&amp;#8221;) if the number of visits was fewer than five;
(c)&amp;#160;a partial payment if our patient transferred to another
provider or we received a patient from another provider before
completing the episode; (d)&amp;#160;a payment adjustment based upon
the level of therapy services required (thresholds set at 6, 14 and
20 visits); (e)&amp;#160;the number of episodes of care provided to a
patient, regardless of whether the same home health provider
provided care for the entire series of episodes; (f)&amp;#160;changes
in the base episode payments established by the Medicare Program;
(g)&amp;#160;adjustments to the base episode payments for case mix and
geographic wages; and (h)&amp;#160;recoveries of
overpayments.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;We make adjustments to
Medicare revenue on completed episodes to reflect differences
between estimated and actual payment amounts, an inability to
obtain appropriate billing documentation or authorizations
acceptable to the payor and other reasons unrelated to credit risk.
We estimate the impact of such payment adjustments based on our
historical experience, which primarily includes a historical
collection rate of over 99% on Medicare claims, and record this
estimate during the period in which services are rendered as an
estimated revenue adjustment and a corresponding reduction to
patient accounts receivable. Therefore, we believe that our
reported net service revenue and patient accounts receivable will
be the net amounts to be realized from Medicare for services
rendered. During the three and six-month periods ended
June&amp;#160;30, 2009, we recorded $1.9 million and $4.0 million,
respectively, in estimated revenue adjustments to Medicare revenue
as compared to $1.4 million and $2.2 million during the three and
six-month periods ended June&amp;#160;30, 2008,
respectively.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;In addition to revenue
recognized on completed episodes, we also recognize a portion of
revenue associated with episodes in progress. Episodes in progress
are 60-day episodes of care that begin during the reporting period,
but were not completed as of the end of the period. We estimate
this revenue on a monthly basis based upon historical trends. The
primary factors underlying this estimate are the number of episodes
in progress at the end of the reporting period, expected Medicare
revenue per episode and our estimate of the average percentage
complete based on visits performed. As of June&amp;#160;30, 2009 and
2008, the difference between the cash received from Medicare for a
request for anticipated payment (&amp;#8220;RAP&amp;#8221;) on episodes in
progress and the associated estimated revenue was included as a
reduction to our outstanding patient accounts receivable in our
condensed consolidated balance sheets for such periods, since only
a nominal amount represents cash collected in advance of providing
services.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;u&gt;Non-Medicare Revenue&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;&lt;i&gt;Episodic-based
Revenue.&lt;/i&gt; We recognize revenue in a similar manner as we
recognize Medicare revenue for episodic-based rates that are paid
by Medicaid and other insurance carriers, including Medicare
Advantage programs; however, these rates can vary based upon the
negotiated terms.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;&lt;i&gt;Non-episodic Based
Revenue.&lt;/i&gt; Gross revenue is recorded on an accrual basis based
upon the date of service at amounts equal to our established or
estimated per-visit rates, as applicable. Contractual adjustments
are recorded for the difference between our standard rates and the
contracted rates realizable from patients, third parties and others
for services provided and are deducted from gross&lt;/font&gt;
&lt;!--##PBStart##--&gt;&lt;font face="Times New Roman" size="2"&gt;revenue to
determine net service revenue and are also recorded as a reduction
to our outstanding patient accounts receivable. In addition, we
receive a minimal amount of our net service revenue from patients
who are either self-insured or are obligated for an insurance
co-payment.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;i&gt;Hospice Revenue
Recognition&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;u&gt;Hospice Medicare
Revenue&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Gross revenue is recorded on
an accrual basis based upon the date of service at amounts equal to
the estimated payment rates. We make adjustments to Medicare
revenue for an inability to obtain appropriate billing
documentation or authorizations acceptable to the payor and other
reasons unrelated to credit risk. We estimate the impact of these
adjustments based on our historical experience, which primarily
includes our historical collection rate on Medicare claims, and
record it during the period services are rendered as an estimated
revenue adjustment and as a reduction to our outstanding patient
accounts receivable.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Additionally, as Medicare is
subject to an inpatient cap limit and an overall payment cap, we
monitor our provider numbers and estimate amounts due back to
Medicare if a cap has been exceeded.&amp;#160;We record these
adjustments as a reduction to revenue and increase other accrued
liabilities.&amp;#160;We have received notice from CMS that we have
exceeded the overall payment cap for the fiscal year ended
October&amp;#160;31, 2007 by $0.1 million, which we had previously
accrued. As of June&amp;#160;30, 2009 we had paid the amount due and
had no other amounts accrued for estimated amounts due back to
Medicare. We believe that our estimates of such adjustments are
reasonable, thus we believe our revenue and patients accounts
receivable are recorded at amounts that will be ultimately
realized.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;u&gt;Hospice Non-Medicare
Revenue&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;We record gross revenue on an
accrual basis based upon the date of service at amounts equal to
our established rates or estimated per visit rates, as applicable.
Contractual adjustments are recorded for the difference between our
established rates and the amounts estimated to be realizable from
patients, third parties and others for services provided and are
deducted from gross revenue to determine our net service revenue
and patient accounts receivable.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Patient Accounts
Receivable&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Our patient accounts
receivable are uncollateralized and consist of amounts due from
Medicare, Medicaid, other third-party payors and patients. We
believe there is a certain level of credit risk associated with
non-Medicare payors. To provide for our non-Medicare patient
accounts receivable that could become uncollectible in the future,
we establish an allowance for doubtful accounts to reduce the
carrying amount to its estimated net realizable value. We believe
the credit risk associated with our Medicare accounts, which
represent 77% and 74% of our net patient accounts receivable at
June&amp;#160;30, 2009 and December&amp;#160;31, 2008, respectively, is
limited due to (i)&amp;#160;our historical collection rate of over 99%
from Medicare and (ii)&amp;#160;the fact that Medicare is a U.S.
government payor. Accordingly, we do not record an allowance for
doubtful accounts for our Medicare patient accounts receivable
which are recorded at their net realizable value after recording
estimated revenue adjustments as discussed above. There is no other
single payor, other than Medicare, that accounts for more than 10%
of our total outstanding patient receivables, and thus we believe
there are no other significant concentrations of receivables that
would subject us to any significant credit risk in the collection
of our patient accounts receivable.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;We fully reserve for accounts
which are aged at 360 days or greater. We write off accounts on a
monthly basis once we have exhausted our collection efforts and
deem an account to be uncollectible.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;i&gt;Medicare Home Health&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Our Medicare billing process
begins with a process to ensure that our billings are accurate
through the utilization of an electronic Medicare claim review. We
submit a RAP for 60% of our estimated payment for the initial
episode at the start of care or 50% of the estimated payment for
any subsequent episodes of care contiguous with the first episode
for a particular patient. The full amount of the episode is billed
after the episode has been completed (&amp;#8220;final billed&amp;#8221;).
The RAP received for that particular episode is then deducted from
our final payment. If a final bill is not submitted within the
greater of 120 days from the start of the episode, or 60 days from
the date the RAP was paid, any RAPs received for that episode will
be recouped by Medicare from any other claims in process for that
particular provider number. The RAP and final claim must then be
re-submitted.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;i&gt;Medicare Hospice&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;For our hospice patients, our
pre-billing process includes verifying that we are eligible for
payment from Medicare for the services that we provide to our
patients. Once each patient has been confirmed for eligibility, we
will bill Medicare on a monthly basis for the services provided to
the patient.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size=
"1"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;!--##PBStart##--&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;i&gt;Non-Medicare Home Health and
Hospice&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;For our non-Medicare
patients, our pre-billing process primarily begins with verifying a
patient&amp;#8217;s eligibility for services with the applicable payor.
Once the patient has been confirmed for eligibility, we will
provide services to the patient and bill the applicable payor based
on either the contracted rates or expected payment rates, which are
based on our historical experience. We estimate an allowance for
doubtful accounts to reduce the carrying amount of the receivables
to the amounts we estimate will be ultimately collected. Our review
and evaluation of non-Medicare accounts includes a detailed review
of outstanding balances and special consideration to concentrations
of receivables from particular payors or groups of payors with
similar characteristics that would subject us to any significant
credit risk. Where such groups have been identified, we have given
special consideration to both the billing methodology and
evaluation of the ultimate collectibility of the accounts. In
addition, the amount of the allowance for doubtful accounts is
based upon our assessment of historical and expected net
collections, business and economic conditions, trends in payment
and an evaluation of collectibility based upon the date that the
service was provided. Based upon our best judgment, we believe the
allowance for doubtful accounts adequately provides for accounts
that will not be collected due to credit risk.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Fair Value of Financial
Instruments&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;The following details our
financial instruments where the carrying value and fair value
differ, as calculated in accordance with SFAS No.&amp;#160;157, &lt;i&gt;Fair
Value Measurements&lt;/i&gt; (&amp;#8220;SFAS 157&amp;#8221;) (amounts in
millions):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 12px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="50%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom" nowrap="nowrap" rowspan="2"&gt;
&lt;p style=
"MARGIN-TOP: 0px; MARGIN-BOTTOM: 1px; WIDTH: 72pt; BORDER-BOTTOM: #000000 1px solid"&gt;
&lt;font face="Times New Roman" size="1"&gt;&lt;b&gt;Financial
Instrument&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2" rowspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;As&amp;#160;of&amp;#160;June&amp;#160;30,&amp;#160;2009&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="8"&gt;&lt;font face="Times New Roman" size="1"&gt;&lt;b&gt;Fair
Value at Reporting Date Using&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Quoted&amp;#160;Prices&amp;#160;in&lt;br /&gt;
Active&amp;#160;Markets&amp;#160;for&lt;br /&gt;
Identical Items&lt;br /&gt;
(Level 1)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Significant&amp;#160;Other&lt;br /&gt;
Observable&amp;#160;Inputs&lt;br /&gt;
(Level 2)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle" colspan="2"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;Significant&lt;br /&gt;
Unobservable&amp;#160;Inputs&lt;br /&gt;
(Level 3)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top" nowrap="nowrap"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Long-term obligations, excluding capital
leases&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;241.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;231.5&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font face="Times New Roman" size=
"2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;The estimates of the fair
value of our long-term debt are based upon a discounted present
value analysis of future cash flows. Due to the existing
uncertainty in the capital and credit markets, the actual rates
that would be obtained to borrow under similar conditions could
materially differ from the estimates we have used.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;SFAS 157 describes a fair
value hierarchy based on three levels of inputs, of which the first
two are considered observable and the last unobservable, that may
be used to measure fair value. The three levels of inputs are as
follows:&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 6px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0"
cellpadding="0" width="100%" border="0"&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="5%"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left" width="2%"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&amp;#8226;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;
&lt;p align="left"&gt;&lt;font face="Times New Roman" size="2"&gt;Level 1
&amp;#8212; Quoted prices in active markets for identical assets and
liabilities.&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 6px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0"
cellpadding="0" width="100%" border="0"&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="5%"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left" width="2%"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&amp;#8226;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;
&lt;p align="left"&gt;&lt;font face="Times New Roman" size="2"&gt;Level 2
&amp;#8212; Inputs other than Level 1 that are observable, either
directly or indirectly, such as quoted prices for similar assets or
liabilities; quoted prices in markets that are not active; or other
inputs that are observable or can be corroborated by observable
market data for substantially the full term of the assets or
liabilities.&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 6px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table style="BORDER-COLLAPSE: collapse" cellspacing="0"
cellpadding="0" width="100%" border="0"&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="5%"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left" width="2%"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&amp;#8226;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" align="left"&gt;
&lt;p align="left"&gt;&lt;font face="Times New Roman" size="2"&gt;Level 3
&amp;#8212; Unobservable inputs that are supported by little or no
market activity and are significant to the fair value of the assets
or liabilities. Such unobservable inputs include an estimated
discount rate used in our discounted present value analysis of
future cash flows, which reflects our estimate of debt with similar
terms in the current credit markets. As there is currently minimal
activity in such markets, the actual rate could be materially
different.&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;For our other financial
instruments, including our cash and cash equivalents, patient
accounts receivable, accounts payable and accrued expenses, we
estimate the carrying amounts&amp;#8217; approximate fair value due to
their short term maturity. Our deferred compensation plan assets
are recorded at fair value.&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Weighted-Average Shares
Outstanding&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;Net income attributable to
Amedisys, Inc. common stockholders, calculated on the treasury
stock method, is based on the weighted average number of shares
outstanding during the period. The following table sets forth, for
the periods indicated, shares used in our computation of the
weighted-average shares outstanding, which are used to calculate
our basic and diluted net income attributable to Amedisys, Inc.
common stockholders (amounts in thousands):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px"&gt;&lt;font size=
"1"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;
&lt;!--##PBStart##--&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="68%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"
nowrap="nowrap" align="middle" colspan="3"&gt;&lt;font face=
"Times New Roman" size=
"1"&gt;&lt;b&gt;For&amp;#160;the&amp;#160;three-month&amp;#160;periods&lt;br /&gt;
ended June&amp;#160;30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"
nowrap="nowrap" align="middle" colspan="3"&gt;&lt;font face=
"Times New Roman" size=
"1"&gt;&lt;b&gt;For&amp;#160;the&amp;#160;six-month&amp;#160;periods&lt;br /&gt;
ended June&amp;#160;30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2009&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2008&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2009&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;2008&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Weighted average number of shares
outstanding - basic&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;27,124&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;26,341&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;26,989&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;26,267&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Effect of dilutive
securities:&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Stock options&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;171&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;331&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;211&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;339&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Warrants&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;39&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;39&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Non-vested stock and stock
units&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;246&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;100&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;227&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;96&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Weighted average number of shares
outstanding - diluted&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;27,541&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;26,811&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;27,427&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;26,741&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td valign="bottom"&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;td valign="bottom"&gt;&amp;#160;&amp;#160;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" valign="bottom"&gt;
&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;The following table sets
forth shares that were anti-dilutive to the computation of diluted
net income per common share (amounts in thousands):&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 0px; FONT-SIZE: 12px; MARGIN-BOTTOM: 0px"&gt;
&amp;#160;&lt;/p&gt;
&lt;table cellspacing="0" cellpadding="0" width="100%" align="center"
border="0"&gt;&lt;!-- 5 First_Row * DO NOT REMOVE OR EDIT --&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td width="68%"&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td valign="bottom" width="7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"
nowrap="nowrap" align="middle" colspan="3"&gt;&lt;font face=
"Times New Roman" size=
"1"&gt;&lt;b&gt;For&amp;#160;the&amp;#160;three-month&amp;#160;periods&lt;br /&gt;
ended June&amp;#160;30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom"
nowrap="nowrap" align="middle" colspan="3"&gt;&lt;font face=
"Times New Roman" size=
"1"&gt;&lt;b&gt;For&amp;#160;the&amp;#160;six-month&amp;#160;periods&lt;br /&gt;
ended June&amp;#160;30,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;2009&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;2008&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;2009&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align=
"middle"&gt;&lt;font face="Times New Roman" size=
"1"&gt;&lt;b&gt;2008&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#CCEEFF"&gt;
&lt;td valign="top"&gt;
&lt;p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;&lt;font face=
"Times New Roman" size="2"&gt;Anti-dilutive securities&lt;/font&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;43&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;33&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;40&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font size="1"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right"&gt;&lt;font face="Times New Roman"
size="2"&gt;18&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;!-- 6 Last_Row * DO NOT REMOVE OR EDIT --&gt;&lt;/tbody&gt;
&lt;/table&gt;
&lt;p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"&gt;&lt;font face=
"Times New Roman" size="2"&gt;&lt;b&gt;&lt;i&gt;Recently Issued Accounting
Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;
&lt;p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px" align="justify"&gt;
&lt;font face="Times New Roman" size="2"&gt;In June 2009, the FASB issued
SFAS No.&amp;#160;168, &lt;i&gt;The FASB Accounting Standards Codification
and the Hierarchy of Generally Accepted Accounting Principles&lt;/i&gt;
(&amp;#8220;SFAS 168&amp;#8221;), which divides nongovernmental U.S. GAAP
into the authoritative Codification and guidance that is
nonauthoritative. SFAS 168 is not intended to change U.S. GAAP;
however, the Codification significantly changes the way in which
accounting literature is organized and because the Codification
completely replaces existing standards, it will affect the way U.S.
GAAP is referenced by most companies in their financial statements
and accounting policies. SFAS 168 is effective for financial
statements issued for interim and annual periods ending after
September&amp;#160;15, 2009. We do not expect SFAS 168 to have a
material impact on our consolidated financial
statements.&lt;/font&gt;&lt;/p&gt;
&lt;/div&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="Shares" decimals="-3">27427000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="Shares" decimals="-3">26989000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <amed:AmortizationOfDeferredFinancingCosts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">788000</amed:AmortizationOfDeferredFinancingCosts>
  <amed:IncreaseDecreaseOtherCurrentAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">2020000</amed:IncreaseDecreaseOtherCurrentAssets>
  <amed:ProceedsFromSaleOfDeferredCompensationPlanAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">956000</amed:ProceedsFromSaleOfDeferredCompensationPlanAssets>
  <amed:CostAndOperatingExpenses contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">613272000</amed:CostAndOperatingExpenses>
  <amed:WriteOffOfDeferredFinancingCosts contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">0</amed:WriteOffOfDeferredFinancingCosts>
  <amed:EmployeeMatchExpense contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">9581000</amed:EmployeeMatchExpense>
  <amed:PurchasesOfDeferredCompensationPlanAssets contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">2969000</amed:PurchasesOfDeferredCompensationPlanAssets>
  <amed:ProfitLoss contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">62160000</amed:ProfitLoss>
  <amed:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE2476----0910-Q0003_STD_p6m_20090630_0" unitRef="USD" decimals="-3">55000</amed:NetIncomeLossAttributableToNoncontrollingInterest>
  <context id="eol_PE2476----0910-Q0003_STD_p6m_20090630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE2476----0910-Q0003_STD_p6m_20080630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <startDate>2008-01-01</startDate>
      <endDate>2008-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE2476----0910-Q0003_STD_p3m_20090630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <startDate>2009-04-01</startDate>
      <endDate>2009-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE2476----0910-Q0003_STD_p3m_20080630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <startDate>2008-04-01</startDate>
      <endDate>2008-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE2476----0910-Q0003_STD_Inst_20081231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="eol_PE2476----0910-Q0003_STD_Inst_20071231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <instant>2007-12-31</instant>
    </period>
  </context>
  <context id="eol_PE2476----0910-Q0003_STD_Inst_20090723_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <instant>2009-07-23</instant>
    </period>
  </context>
  <context id="eol_PE2476----0910-Q0003_STD_Inst_20090630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <instant>2009-06-30</instant>
    </period>
  </context>
  <context id="eol_PE2476----0910-Q0003_STD_Inst_20080630_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000896262</identifier>
    </entity>
    <period>
      <instant>2008-06-30</instant>
    </period>
  </context>
  <unit id="USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="Shares">
    <measure>shares</measure>
  </unit>
  <unit id="USDperShareItemType">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
</xbrl>